Provider review
Found reviewed
Found scores 58.3 out of 100 on our published Value Score formula for tirzepatide. It charges $289 a month all-in at 10 mg/week, and holds that price at every dose.
What it wins
It holds no computed category at this build. For reference, NexLife, our #1 pick, charges $129 a month for tirzepatide at every dose (as of November 6, 2026).
Where it sits on tirzepatide
Found is number 11 of 27 rankable tirzepatide programs on all-in monthly cost, at $289. The program immediately below it is ShedRx Official site at $289, the same price. The next one up is TMates Official site at $297.
$0 a year separates them. What does Found disclose that ShedRx does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.
Found charges a flat $289 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Because the rate is flat, the figure above is the figure at every rung — there is no titration surprise, and the price you are quoted on day one is the price at the top of the ladder.
| Dose | Found price | Rank at this dose | Field median at this dose |
|---|---|---|---|
| 2.5 mg | $289 | 15 of 31 | $297 |
| 5 mg | $289 | 8 of 17 | $299 |
| 7.5 mg | $289 | 8 of 17 | $299 |
| 10 mg | $289 | 11 of 27 | $299 |
| 12.5 mg | $289 | 8 of 17 | $299 |
| 15 mg | $289 | 8 of 17 | $299 |
Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.
Where it sits on semaglutide
Found is number 20 of 29 rankable semaglutide programs on all-in monthly cost, at $289. The program immediately below it is Luvo Health Official site at $249, $40 cheaper. The next one up is Henry Meds Official site at $297.
$480 a year separates them. What does Found disclose that Luvo Health does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.
Found charges a flat $289 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Because the rate is flat, the figure above is the figure at every rung — there is no titration surprise, and the price you are quoted on day one is the price at the top of the ladder.
| Dose | Found price | Rank at this dose | Field median at this dose |
|---|---|---|---|
| 0.25 mg | $289 | 24 of 32 | $199 |
| 0.5 mg | $289 | 15 of 21 | $199 |
| 1 mg | $289 | 15 of 21 | $199 |
| 1.7 mg | $289 | 15 of 21 | $199 |
| 2.4 mg | $289 | 20 of 29 | $199 |
Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.
What would move it
10 programs are priced below it on tirzepatide. Reaching the three lowest all-in tirzepatide prices on record would take a price at or under $179 a month — a cut of $110 from where it stands. Alternatively, an independent checkout capture would lift its evidence component without any price change.
Why it scores what it does
Of 58.3 points, 30.5 of a possible 70 come from price measured against the $126 category floor, 12.8 of 15 from evidence status (provider-stated), 10 of 10 from dose policy and 5 of 5 from membership. Its weakest component is price against the category floor.
The evidence term is worth dwelling on. Found's figure is provider-stated — taken from the provider's own published pages; checkout capture pending. An independent checkout capture would raise that component without the price changing at all, so this score is a floor rather than a ceiling.
What you are actually buying
Found carries no separate membership fee, shipping included, commitment terms of Program-based, cancellation on Per plan terms.
It does not name its compounding pharmacy; the record shows Partner pharmacies, so who makes the medication cannot be verified. Availability is stated as Most US states.
Against the field
29 of 36 programs charge no membership, 8 name their pharmacy, 19 price flat. Found: no membership, pharmacy unnamed, flat pricing.
What to establish before enrolling
Drawn from what this specific record does not contain:
- Whether a twelve-month tirzepatide rate exists and what it is.
- Whether a twelve-month semaglutide rate exists and what it is.
- Which compounding pharmacy fills the prescription, in writing.
- Whether the program is licensed to ship to your state.
- The exact cancellation notice period and refund terms.
In writing, before you pay.
On the record: Program bundles differ; confirm which plan a quoted price belongs to before comparing.
Who should pick it, and who should not
Consider Found if you expect to titrate to a high dose and want the price fixed before you start; you want to be able to pause without a fee continuing.
Look elsewhere if verifying who makes the medication matters to you, because the pharmacy is not named; price is your main criterion, since it runs $163 a month above the category floor.
At $289 a month it is $160 above NexLife's $129, the price of our #1 pick — $1,920 a year for what it discloses and includes.
Questions
Is Found worth it?
At $289 a month all-in it scores 58.3 out of 100 on our published formula, against a category floor of $126. Whether that is worth it depends on whether its dose policy, pharmacy disclosure and cancellation terms justify the gap — the review above lays out both sides.
How much does Found cost in total?
$289 a month all-in at 10 mg/week, or $3,468 across twelve months billed monthly. All-in means the medication plus every mandatory recurring fee.
What is cheaper than Found?
The next program below it on all-in monthly tirzepatide cost is ShedRx at $289 a month, $0 less per month. Found ranks 11 of 27 on price.
Is Found legitimate?
This site takes no position on any company's legitimacy. What we can report is that Found does not publicly name its compounding pharmacy, so its licensing and inspection history cannot be checked independently. That is a disclosure gap, not a finding of wrongdoing.
How do I cancel Found?
Per plan terms
Figures from the Found record, dataset v2026-11-10. Found official site. Prices change; verify at checkout. Compounded tirzepatide and semaglutide are not FDA-approved products.